Home > Boards > US OTC > Medical - Drugs >

Vilacto Bio Inc (VIBI)

VIBI RSS Feed
Add VIBI Price Alert      Hide Sticky   Hide Intro
Moderator: UnderR8D, TKane, Bud-Wiser
Search This Board: 
Last Post: 8/2/2021 3:08:17 PM - Followers: 295 - Board type: Free - Posts Today: 4












 


SEC Order to Show Cause: https://www.sec.gov/litigation/opinions/2021/34-92157.pdf








Grey Market trading begins May 28, 2021 at 9:30 AM







VIBI - SEC SUSPENSION EFFECTIVE MAY 13, 2021









https://otce.finra.org/otce/tradingHalts





 

SEC CASE# 34-91891 - May 13, 2021 - Vilacto

 




 

https://www.otcmarkets.com/stock/VIBI/disclosure

 


 


https://investorshub.advfn.com/DD-Support-Board-and-Research-Team-19670/





 
 


PATENTS AND INTELLECTUAL PROPERTY RIGHTS

We protect our proprietary therapeutic products, assets and technologies by seeking and maintaining both domestic and international patent rights. These may cover products, compositions, methods of use, manufacturing processes, and other inventions that may be important to our business strategy. We also rely on trade secrets to protect aspects of our business.

Our competitive position depends on our ability to obtain patents on our technologies and our potential products, to defend our patents, to protect our trade secrets and to operate without infringing valid and enforceable patents or trade secrets of others. We seek licenses from others as appropriate to enhance or maintain our competitive position.

According to Patent No 8,637,075. a nanoparticle composition comprising colostrum Lactoactive® is formulated for treating diseases and/or conditions. Relieving the limited status due to the poor mechanical properties, rapid degradation, and in vivo clearance when bovine colostrum is used, our Lactoactive® is valuable to modify new bio/pharmaceutical industries.

In connection with our programs under Topical Drug, Systemic Drug & Supplement, and Cosmetics we hold a worldwide, perpetual, non-exclusive, license, with the right to sublicense, all the intellectual property related to the composition of matter of Topical Drug, Systemic Drug & Supplement and Cosmetics and plan to file U.S. and international patent applications.



https://microcapdaily.com/inside-scoop-on-vilacto-bio-inc-otcmkts-vibi/122822/
The Company recently announced it has revealed the initial five areas of development for its new LACTOACTIVE iTHER® compound. These include a bio-injection that could be useful in preventing metastasis of malignant tumor cells in cancer treatment due to the hydrocolloid potent (HA). An inhaler spray to prevent recurrent upper respiratory tract infections (based on a 2016 study. A vaccine injection for nanoparticle antibody source for a vaccine producer or a new variant of gelatin capsules for patients with arthritis and other joint inflammation with fewer side effects – especially hypertension if people with diabetes – than Glucosamine.

LACTOACTIVE iTHER® is a new LACTOACTIVE variant that combines potent immune-system enhancement with a proven nanoparticle drug delivery system. These development programs are part of Vilacto Bio’s LACTOACTIVE iTHER® plan to form strategic partnerships with other biotech firms and become the “go-to” partner for enhancing new immunotherapy and vaccine solutions with its refined-colostrum compound “weaponized” as a nanomedicine.

https://microcapdaily.com/inside-scoop-on-vilacto-bio-inc-otcmkts-vibi/122822/
Inside Scoop on Vilacto Bio Inc (OTCMKTS: VIBI)
BY DANIEL MCCARTHY ON DECEMBER 27, 2018


Vilacto Bio Inc (OTCMKTS: VIBI) is an exciting stock that popped to $0.70 a share in October but has been dropping steadily since than recently hitting single digits.

Vilacto Bio Inc is a biotech company that has developed the now fully patented Lactoactive® (Lactoactive molecule) that in numerous studies has demonstrated above average effect treating conditions such as inflammatory diseases, diabetes, psoriasis, skin aging, and skin issues in different levels. The Company aims to further develop the Lactoactive® molecule for the purpose of increasing the quality of retail and medical skin cream products as well as licensing Lactoactive® molecule for the pharmaceutical industry.

The Company recently announced it has revealed the initial five areas of development for its new LACTOACTIVE iTHER® compound. These include a bio-injection that could be useful in preventing metastasis of malignant tumor cells in cancer treatment due to the hydrocolloid potent (HA). An inhaler spray to prevent recurrent upper respiratory tract infections (based on a 2016 study. A vaccine injection for nanoparticle antibody source for a vaccine producer or a new variant of gelatin capsules for patients with arthritis and other joint inflammation with fewer side effects – especially hypertension if people with diabetes – than Glucosamine.

LACTOACTIVE iTHER® is a new LACTOACTIVE variant that combines potent immune-system enhancement with a proven nanoparticle drug delivery system. These development programs are part of Vilacto Bio’s LACTOACTIVE iTHER® plan to form strategic partnerships with other biotech firms and become the “go-to” partner for enhancing new immunotherapy and vaccine solutions with its refined-colostrum compound “weaponized” as a nanomedicine.

VIBI CEO Gert Anderson stated “Our own research suggests, and we firmly believe, that LACTOACTIVE iTHER® can contribute significantly to emerging therapies for treating a number of diseases, including cancer, immunodeficiency disorders, osteoarthritis, psoriasis, thrombocytopenia and others.”

Earlier this year Vilacto Bio completed a two-month upgrade to the Denmark production facility, which is owned by Pharma GP, that produces its patented LACTOACTIVE nanoparticle compound. This upgrade will enable the company to manufacture even smaller LACTOACTIVE particles and enable Vilacto Bio to start production of its new LACTOACTIVE iTHER®.

In October VIBI announced it has launched its new skincare product, Carmen Electra by Vilact, based on the company’s LACTOACTIVE® compound. LACTOACTIVE® is the first variant of a patented particle the company has used to produce a range of popular skincare products. Customers have given Carmen Electra by Vilact rave reviews, and the new product won the “Buyers’ Choice” award at a ECRM event held in Las Vegas in June.

In addition to using the LACTOACTIVE® compound in its skin creams – now spun off as a separate business unit – Vilacto Bio is moving into biotech with its new LACTOACTIVE iTHER® compound. In the long run, Vilacto Bio expects LACTOACTIVE iTHER® to help develop further and even more powerful skincare solutions, along with therapeutic treatments for a range of medical conditions.

On November 30 VIBI announced it has secured the patent applications for LACTOACTIVE® covering rights in the US, Canada Europe and Hong Kong. The transaction was finalized this November. Ownership of the patent applications, which Vilacto Bio had been licensing the US rights from a Danish company, is expected to give the company greater scope to continue developing the LACTOACTIVE® compound, and bolster its international IP ownership position.

The patent applications also cover the company’s new compound, LACTOACTIVE iTHER®, a LACTOACTIVE® variant that offers potent immune-system enhancement with a potential for treating a wide range of diseases. LACTOACTIVE iTHER® is expected to generate new revenue streams in addition to the company’s LACTOACTIVE®-based therapeutic skincare range..”

The main active component of LACTOACTIVE® and LACTOACTIVE iTHER® is colostrum, a natural substance that Vilacto Bio has refined and processed into a potent nanoparticle concentrate. In NPDDS form, the compound can be applied in deeper layers of the skin and, when injected, can penetrate cell walls to act directly on cytoplasm. The product is currently in the development stage and has not been approved for use by the FDA or any foreign agency.



 

-------------------------------------------------------------------------------------Nothng to be put above this line-------------------------------------------------------------------------


 

THE FULL LINE OF VILACT® PRODUCTS

Vilact® products are the sole source of our breakthrough, patented SUPER-MOLECULE Lactoactive®, which regenerates skin at the cellular level, repairing and restoring aged and damaged skin.

Vilact® products penetrates skin deeper and more effectively than other premium skincare products, while being suitable for all skin types and offering restoration for sensitive skin caused by factors such as irritation, itchiness, eczema and atopic dermatitis.

Vilact | Skin Lotion with Almond Oil, Jojoba Oil, Shea butter, and Lactoactive® by Vilact® (4.2 FL.OZ / 125ml)
 
Vilact | Skin Cream for Sensitive Skin with Lactoactive® by Vilact® (4.2 FL.OZ / 125ml)
 
Vilact | Carmen Electra by Vilact® Skin Cream for Sensitive Skin with Lactoactive® (3.38 FL. OZ / 100ml)
 
 
Vilact | Skin Cream for Sensitive Skin Clinical Pump with Lactoactive® by Vilact® (16.9 FL.OZ / 500ml)
 
Vilacto | Lip Balm for Dry and Cracked Lips with Lactoactive® by Vilact® (.5 FL.OZ / 15ml)
 
 
Vilact | 24/7 Foot Cream with Lactoactive® by Vilact® (3.38 FL.OZ / 100ml)
 
 
 
 
 
 
NEWS & UPDATES

Sign up to get the latest on sales, new releases and more…

 

 
ABOUT VILACT®

Vilact® is produced by Vilacto Bio, an American company with roots in Scandinavia and that specializes in applying its patented Lactoactive® particle matrix within skincare and pharmaceutical applications.

 

Vilact® soothes and repairs skin like no other skincare product – even slowing the skin-aging process.

Our products can undo years of damage from environmental factors, restoring skin in virtually any condition a healthier, more youthful state






 
 
Beware: VIBI has a Grey Market Skull & Crossbones status, for non-compliance with SEC.


It is not disclosing current finances or current operating status to the SEC or to its own shareholders.






 





 




SEC Order to Show Causehttps://www.sec.gov/litigation/opinions/2021/34-92157.pdf








Grey Market trading begins May 28, 2021 at 9:30 AM







VIBI - SEC SUSPENSION EFFECTIVE MAY 13, 2021









https://otce.finra.org/otce/tradingHalts





 

SEC CASE# 34-91891 - May 13, 2021 - Vilacto

 




 

https://www.otcmarkets.com/stock/VIBI/disclosure

 


 


https://investorshub.advfn.com/DD-Support-Board-and-Research-Team-19670/





 
 








 



 

PER  IHUB  MGMT 




02-07-2021 DISCLAIMER:  ONLY FOR MICK
https://investorshub.advfn.com/boards/profilea.aspx?user=1012
*The Board Monitor and herewithin , are not licensed brokers and assume NO responsibility for actions,
investments,decisions, or messages posted on this forum.
 
CONTENT ON THIS FORUM SHOULD NOT BE CONSIDERED ADVISORY NOR SOLICITATION 
AUTHORS MAY HAVE BUYS OR SELLS  WITH THE COMPANIES MENTIONED IN TRADING POSTERS SHOULD DUE DILIGENT BUYING OR SELLING.
ALL POSTING SHOULD BE CONSIDERED FOR INFORMATION ONLY. WE DO NOT RECOMMEND ANYONE BUY OR SELL ANY SECURITIES POSTED HEREWITHIN.

ANY trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.
Any



 




Maintained by Pro-Life:

$VIBI - Vilacto Bio ?? Cantabio Pharmaceuticals
  -   
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=163403040   -   And, found on Twitter from gobucks21  -   https://twitter.com/brianlanning8/status/1385363934597640194?s=21

Active $VIBI Customer Portal   -   https://vilacto.com   -   Active $VIBI Website   -   https://vilactobio.com   -   $VIBI Neveada SOS   -    https://esos.nv.gov/EntitySearch/OnlineEntitySearch   -   $VIBI Open Corporates   -   https://opencorporates.com/companies/dk/37014893




 

VIBI
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
VIBI News: ALKM TRADING VOLUME ALERT 04/30/2021 12:19:23 PM
VIBI News: Statement of Ownership (sc 13g) 03/08/2021 11:32:55 AM
PostSubject
#23484  Sticky Note If VIBI does not respond to the Order Renee 06/23/21 04:15:06 PM
#22981  Sticky Note $VIBI - Vilacto Bio Inc ?? Vilacto BioIP, Stock Caller 05/04/21 09:47:49 AM
#23534   https://www.vilactobio.com/ 02opida 08/02/21 03:08:17 PM
#23533   good product too 02opida 08/02/21 03:05:05 PM
#23532   Vilacto Bio In SELL 02opida 08/02/21 03:04:44 PM
#23531   much higher come 2022 4 VIBI 02opida 08/02/21 03:04:14 PM
#23530   Just checking in, I see Vibi is down blazinw418 07/20/21 10:10:53 AM
#23529   The latest one from Td Ameritrade bassman711 07/17/21 06:52:35 AM
#23528   Just checking in…Still trading I see …LMAO …Morons Bud-Wiser 07/16/21 07:15:57 PM
#23527   Huh ? Which list ? UnderR8D 07/16/21 05:14:12 PM
#23526   VIBI is no longer on the latest Retricted bassman711 07/16/21 11:03:54 AM
#23525   I actually had a dream that trading closed SJVB 07/16/21 07:46:26 AM
#23524   What’s with the 60+ mil in volume ? UnderR8D 07/13/21 08:53:47 PM
#23523   There is NEVER bad information posted here ?? gobucks21 07/07/21 09:09:34 PM
#23522   I'm down a lot money personally ? hangs WallStreetMyWay 07/07/21 07:27:37 PM
#23521   No idea what that means. UnderR8D 07/07/21 01:40:13 PM
#23520   Look at my accounts I'm way down apposed? WallStreetMyWay 07/06/21 07:37:56 PM
#23519   Wait, what ? UnderR8D 07/06/21 04:42:53 PM
#23518   I want too see this revelry as well WallStreetMyWay 07/06/21 03:49:16 PM
#23517  Restored Still going Strong and Trading…Bad information was posted Bud-Wiser 07/06/21 02:20:14 PM
#23516   FS, please refer to posts 23484, 23487, 23490. TKane 07/02/21 10:36:11 PM
#23515   When will this stop trading? tia FlippinSheers 07/02/21 09:16:03 AM
#23514   Yep Last Friday …LMAO …More bad info was Bud-Wiser 07/01/21 09:48:53 AM
#23513   I thought this was supposed to stop trading Bud-Wiser 07/01/21 07:23:57 AM
#23512   Lol ok :) UnderR8D 06/28/21 04:58:16 PM
#23511   Dunno, busy day, hence the link for all. TKane 06/28/21 03:20:24 PM
#23510   VIBI not revoked yet , right ? UnderR8D 06/28/21 03:17:06 PM
#23509   The FINRA Daily List: Registration Revoked by SEC: 6/28/21 TKane 06/28/21 11:25:07 AM
#23508   Basically, no one knows the day or hour, TKane 06/26/21 05:23:56 PM
#23507   It won’t happen that fast, never does. It’ll UnderR8D 06/26/21 02:00:54 PM
#23506   Nothing on SEC EDGAR for VIBI from 6/21-25! TKane 06/26/21 12:33:34 PM
#23505   Did they respond ? UnderR8D 06/25/21 06:51:56 PM
#23504   What's it matter if Vilacto is going private? TKane 06/25/21 04:26:38 PM
#23503   What happened to the Canadian patent? Gert needs to update Serge521 06/25/21 03:20:35 PM
#23502   I mean , there has to be a UnderR8D 06/25/21 02:22:00 PM
#23501   Could tour as a Megadeth tribute band, Viladeath. TKane 06/25/21 01:33:26 PM
#23500   Volume up ticked today for whatever reason UnderR8D 06/25/21 01:23:42 PM
#23499   Guess so. It's after 5 PM in Denmark. TKane 06/25/21 11:35:19 AM
#23498   Agreed, the SEC is “relentless” and “Annoying” but TKane 06/25/21 05:52:03 AM
#23497   Is relentless..... Annoying RPh1 06/25/21 03:12:47 AM
#23496   Is what it is at this point. Those UnderR8D 06/24/21 08:58:11 PM
#23495   "will be too late to recover any money TKane 06/24/21 11:46:57 AM
#23494   Extra time...for what? They were fully well aware TKane 06/24/21 11:26:29 AM
#23493   Why not be the Pres. of a private TKane 06/24/21 11:18:29 AM
#23492   So my understanding of what you are saying RPh1 06/24/21 11:01:08 AM
#23491   But why even bother if you have no RPh1 06/24/21 10:57:45 AM
#23490   No-one can accurately guess when the A.L.J. will Renee 06/24/21 10:12:57 AM
#23489   Is that "soon" as in immediately? Maybe Monday? TKane 06/24/21 10:08:07 AM
#23488   Incorporations, whether private or public, usually require a BOD, TKane 06/24/21 09:29:25 AM
#23487   There is no specific timeline for the A.L.J. Renee 06/24/21 09:24:43 AM
#23486   This is actually true. Not sure what the UnderR8D 06/23/21 11:38:19 PM
#23485   How long does that process usually take? Is UnderR8D 06/23/21 10:28:36 PM
PostSubject
Consent Preferences